Search images on Google      Product Monograph

Active Ingredients:

• bicisate dihydrochloride, 0.9 MG/VIAL

DIN: 02327848

Dosage Form(s): KIT, POWDER FOR SOLUTION

Route(s) of Administration: INTRAVENOUS

Schedule: Schedule C

Company: LANTHEUS MI CANADA INC

ATC:

• V09 - DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, WHO, Wiki)
• V09A - CENTRAL NERVOUS SYSTEM (ATC, WHO)
• V09A - CENTRAL NERVOUS SYSTEM (ATC, WHO)
• V09A - CENTRAL NERVOUS SYSTEM (WHO)

Packaging:

• Package size unit: No information
• Package type: No information
• Package size: No information
• Product information: 2 OR 5 KITS (VIAL A AND VIAL B)

 

External Links for Neurolite:

Search on Google

• Neurolite side effects
• Neurolite dosage
• bicisate dihydrochloride side effects
• bicisate dihydrochloride dosage